Literature DB >> 7539174

Pathophysiology of clinical benign prostatic hyperplasia.

E Shapiro1, H Lepor.   

Abstract

The pathophysiology of clinical BPH has been attributed to bladder outlet obstruction resulting from the enlarged prostate. A direct relationship does not exist between prostate size, symptom severity, or bladder outlet obstruction. The pathophysiology of prostatism is most likely multifactorial. Elucidating the factors contributing to symptoms will likely provide the foundation for the development of new pharmacological alternatives for the medical treatment of BPH.

Entities:  

Mesh:

Year:  1995        PMID: 7539174

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  14 in total

1.  Pathophysiology of lower urinary tract symptoms in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

2.  Pathophysiology of benign prostatic hyperplasia in the aging male population.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2005

3.  Correlation between the total volume, transitional zone volume of the prostate, transitional prostate zone index and lower urinary tract symptoms (LUTS).

Authors:  Mario Franciosi; Walter José Koff; Ernani Luis Rhoden
Journal:  Int Urol Nephrol       Date:  2007-01-04       Impact factor: 2.370

4.  Pathophysiology of benign prostatic hyperplasia: insights from medical therapy for the disease.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2009

5.  Evaluating men with benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2004

6.  Quality of life and sexual function in patients with benign prostatic hyperplasia.

Authors:  Reginald C Bruskewitz
Journal:  Rev Urol       Date:  2003

7.  Validity of the "bother score" in the evaluation and treatment of symptomatic benign prostatic hyperplasia.

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2005

8.  Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: functional assessment.

Authors:  Hannah Ruetten; Kyle A Wegner; Helen L Zhang; Peiqing Wang; Jaskiran Sandhu; Simran Sandhu; Brett Mueller; Zunyi Wang; Jill Macoska; Richard E Peterson; Dale E Bjorling; William A Ricke; Paul C Marker; Chad M Vezina
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-07

9.  The effect of in vitro ischemia/reperfusion on contraction, free fatty acid content, phospholipid content, and malondialdehyde levels of the rabbit urinary bladder.

Authors:  Florian Radu; Robert E Leggett; Catherine Schuler; Robert M Levin
Journal:  Mol Cell Biochem       Date:  2010-09-30       Impact factor: 3.396

10.  Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial.

Authors:  Rommel Prata Regadas; Ricardo Reges; João Batista Gadelha Cerqueira; Daniel Gabrielle Sucupira; Iatagan Rocha Josino; Emmanuel Almeida Nogueira; Francisco Vagnaldo F Jamacaru; Manoel Odorico de Moraes; Lúcio Flávio Gonzaga Silva
Journal:  Int Urol Nephrol       Date:  2012-10-30       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.